Review of available infertility treatments

Drugs of Today

Volumn 45, Issue 4, 2009, Pages 275-291

  Hrometz, Sandra L ^a   Gates, Victoria A ^a  

^a OHIO NORTHERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; CHORON 10; CLOMIFENE; CLOMIFENE CITRATE; FOLLISTIM AQ; GANIRELIX; GONADORELIN ACETATE; GONIC; HISTRELIN; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; LEUPRORELIN; NAFARELIN ACETATE; NOVAREL; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; UNCLASSIFIED DRUG; UROFOLLITROPIN;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL INSEMINATION; ASCITES; BONE PAIN; BREAST CANCER; BREAST TENDERNESS; CRYOPRESERVATION; DIAPHORESIS; DIARRHEA; DRUG HALF LIFE; DRUG MECHANISM; DYSPNEA; EDEMA; ELECTROLYTE DISTURBANCE; ESTROGEN BLOOD LEVEL; ESTROGEN SYNTHESIS; FATIGUE; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FLUID RETENTION; HEADACHE; HEMODYNAMICS; HOT FLUSH; HUMAN; HYPERCOAGULABILITY; INFERTILITY THERAPY; INTRAUTERINE INSEMINATION; KIDNEY FAILURE; LIVER FUNCTION TEST; MULTIPLE PREGNANCY; NAUSEA; NIDATION; NIGHT SWEAT; OLIGURIA; OVARY CANCER; OVARY CYST; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; OVARY INSUFFICIENCY; OVULATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; REVIEW; SEXUAL INTERCOURSE; SIDE EFFECT; SUBFERTILITY; TACHYPNEA; THROMBOEMBOLISM; VISUAL DISORDER; VOMITING; WEIGHT GAIN;

AGE FACTORS; CLINICAL TRIALS AS TOPIC; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; OVULATION; OVULATION INDUCTION; PREGNANCY;

EID: 68249095628     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2009.45.4.1360985     Document Type: Review

References (99)

1. Nachtigall, R.D. International disparities in access to infertility services. Fertil Steril 2006, 85(4): 871-875
2. Facts and Figures 2006 Fertility Problems and Treatment. Human Fertilisation & Embryology Authority, available at: http://www.hfea.gov.uk/ docs/Facts and Figures 2006 fertility probs and treatment 2008-10-08.pdf. Accessed April 18, 2009.
3. Infertility Awareness Association of Canada. Available at: http://www.iaac.ca/en/home. Accessed April 18, 2009.
4. Chandra, A., Martinez, G.M., Mosher, W.D., Abma, J.C., Jones, J. Fertility, family planning and reproductive health of U.S. women: Data from the 2002 National Survey of Family Growth. National Center for Health Statistics. Vital Health Stat 2005, 23(25): 1-174.
5. Gnoth, C., Godehardt, D., Godehardt, E., Frank-Herrmann, P., Freundl, G. Time to pregnancy: Results of the German prospective study and impact on the management of infertility. Hum Reprod 2003, 18(9): 1959-1966 (Pubitemid 37107576)
6. Zinaman, M.J., Clegg, E.D., Brown, C.C , O'Connor, J., Selevan, S.G. Estimates of human fertility and pregnancy loss. Fertil Steril 1996, 65(3): 503-509 (Pubitemid 26069103)
7. Brosens, I., Gordts, S., Valkenburg, M., Puttemans, P., Campo, R., Gordts, S. Investigation of the infertile couple: When is the appropriate time to explore female infertility? Hum Reprod 2004, 19(8): 1689-1692
8. National Women's Health Information Center, US Department of Health and Human Services, Office of Women's Health. http://www.womenshealth.gov/faq/ infertility.pdf. Content last updated April 9, 2009. Accessed April 18, 2009.
9. Dunson, D.B., Colombo, B., Baird, D.D. Changes with age in the level and duration of fertility in the menstrual cycle. Hum Reprod 2002, 17(5): 1399-1403 (Pubitemid 34537382)
10. Hall, J.E. Infertility and fertility control. In: Harrison's Principles of Internal Medicine, 16th edition. D.L. Kasper, E. Braunwald, A.S. Fauci, S.L. Hauser, D.L. Longo, J.R. Jameson (Eds.). The McGraw-Hill Companies, Inc: New York 2005, 279-283
11. Lobo, R.A. Potential options for preservation of fertility in women. NEJM 2005, 353(1): 64-73. (Pubitemid 41007808)
12. Macklon, N.S., Stouffer, R.L., Giudice, L.C., Fauser, B. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocrine Rev 2006, 27(2): 170-207.
13. Novak, K.K. Drug Facts and Comparisons. 2007 Edition. St. Louis: Wolters Kluwer Health; 2007.
14. Wu, C.H., Winkel, C.A. The effect of therapy initiation day on clomiphene citrate therapy. Fertil Steril 1989, 52(4): 564-568 (Pubitemid 19250415)
15. Elkind-Hirsch, K.E., Darensbourg, C., Creasy, G., Gipe, D. Conception rates in clomiphene citrate cycles with and without hormone supplementation: A pilot study. Curr Med Res Opin 2005, 21(7): 1035-1040 (Pubitemid 41032692)
16. Fujii, S., Fukui, A., Fukushi, Y., Kagiya, A., Sato, S., Saito, Y. The effects of clomiphene citrate on normal ovulatory women. Fertil Steril 1997, 68: 997-999 (Pubitemid 28013359)
17. Sereepapong, W., Suwajanakom, S., Triratanachat, S., Sampatanukul, P., Pruksananonda, K., Boonkasemsanti, W., Reinprayoon, D. Effects of clomiphene citrate on the endometrium of regularly cycling women. Fertil Steril 2000, 73(2): 287-291 (Pubitemid 30060361)
18. Gelety, T.J., Buyalos, R.P. The effect of clomiphene citrate and menopausal gonadotropins on cervical mucus in ovulatory cycles. Fertil Steril 1993, 60(3): 471-476 (Pubitemid 23278804)
19. Massai, M.R., de Ziegler, D., Lesobre, V., Bergeron, C., Frydman, R., Bouchard, P. Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment. Fertil Steril 1993, 59(6): 1179-1186 (Pubitemid 23163188)
20. Gonen, Y., Casper, R. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 1990, 5(6): 670-674 (Pubitemid 20308440)
21. Eden, J.A., Place, J., Carter, G.D., Jones, J., Alaghband-Zach, J., Pawson, M.E. The effect of clomiphene citrate on follicular phase increase in endometrial thickness and uterine volume. Obstet Gynecol 1989, 73(2): 187-190 (Pubitemid 19046529)
22. Randall, J.M., Templeton, A. Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertil Steril 1991, 56(3): 465-468
23. Nakamura, Y., Ono, M., Yoshida, Y., Sugmo, N., Ueda, K., Kato, H. Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertil Stertil 1997, 67(2): 256-260 (Pubitemid 27052181)
24. Begum, M.R., Quadir, E., Begum, A., Begum, R.A., Begum, M. Role of aromatase inhibitor in ovulation induction in patients with poor response to clomiphene citrate. J Obstet Gynaecol Res 2006, 32(5): 502-506 (Pubitemid 44410982)
25. Lexi-Comp Online (database on the internet). Hudson, (OH): Lexi-comp.2009 (cited 18 April 2009) url http://online.lexi.com/crlsql/servlet/crlonline.
26. Fisher, S.A., Reid, R.L., Van Vugt, D.A., Casper, R.F. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 2002, 78(2): 280-285
27. Holzer, H., Casper, R., Tulandi, T. A new era in ovulation induction. Fertil Steril 2006, 85(2): 277-284
28. Mitwally, M, F., Casper, R.F. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001, 75(2): 305-309
29. Huirne, J.A., Lambalk, C.B., van Loenen, A.C., Schats, R., Hompes, P.G. Fauser, B.C., Macklon, N.S. Contemporary pharmacological manipulation in assisted reproduction. Drugs 2004, 64: 297-322. (Pubitemid 38283045)
30. Balasch, J., Barri, P.N. Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinicians' perspective. J Assist Reprod Genet 2001, 18(2): 45-55. (Pubitemid 32233770)
31. van Wely, M., Andersen, C.Y., Bayram, N., van der Veen, F. Urofollitropin and ovulation induction. Treat Endocrinol 2005, 4(3): 155-165
32. The European Recombinant LH Study Group. Recombinant human luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: Results of a multicenter double-blind study. J Clin Endocrinol Metab 2001, 86(6): 2607-2618
33. Westergaard, L.G., Laursen, S.B, Andersen, C.Y. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 2000, 15(5): 1003-1008
34. Balasch, J , Vidal, E., Penarrubia, J., et al. Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod 2001, 16(8): 1636-1643 (Pubitemid 32761742)
35. van Wely, M., Westergaard, L.G., Bossuyt, P.M., van der Veen, F. Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: A meta-analysis. Fertil Steril 2003, 80(5): 1086-1093 (Pubitemid 37377729)
36. Oliviera J.B., Mauri A.L., Petersen C.G., et al. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone during induced ovarian stimulation in the GnRH-agonist protocol: A meta-analysis. J Assist Reprod Genet 2007, 24: 67-75
37. Fleming, R., Rehka, P., Deshpande, N., Jamieson, M.E., Yates, R.W., Lyall, H. Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH. Hum Reprod 2000, 15(7): 1440-1445 (Pubitemid 30741911)
38. Shoham, Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril 2002, 77(6): 1170-1177 (Pubitemid 34626325)
39. Tesarik, J., Mendoza, C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence Hum Reprod 2002, 17(2): 3129-3137
40. Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril 2006; 86(Suppl 4):S178-83.
41. Mitwally, M.F., Casper, R.F. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation. J Soc Gynecol Invest 2004, 11(6): 406-415
42. Mitwally, M.F., Casper, R.F. Aromatase inhibition reduces gonadotropin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 2003, 18(8): 1588-1597
43. Mitwally, M.F., Casper, R.F. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 2002, 77(4): 776-780
44. Pang, S.C. Use of follicle-stimulating hormone for the treatment of female infertility - current concepts. Women's Health 2005, 1(1): 87-95.
45. van Santbrink, E.J., Eijkemans, M.J., Macklon, N.S. Fauser, B.C. FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility. Eur J Endocrinol 2002, 147(2): 223-226
46. van Santbrink, E.J., Fauser, B.C. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: Prospective, randomized comparison between low dose step-up and step-down dose regimens. J Clin Endocrinol Metab 1997, 82(11): 3597-3602
47. Christin-Maitre, S., Hugues, J.N. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. Hum Reprod 2003, 18(8): 1626-1631 (Pubitemid 36958040)
48. Smitz, J., Devroey, P., Van Steirteghem, A.C. Endocrinology in luteal phase and implantation. Br Med Bull 1990, 46(3): 709-719
49. The International Recombinant Human Chorionic gonadotropin study group. Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: A comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG. Fertil Steril 2001, 75(6). 1111-1118
50. Sakhel, K., Khedr, M., Schwark, S., Ashraf, M., Fakih, M., Abuzeid, M. Comparison of urinary and recombinant human chorionic gonadotropin during ovulation induction in intrauterine insemination cycles: A prospective randomized clinical trial. Fertil Steril 2007, 87(6): 1357-1362 (Pubitemid 46829139)
51. The European Recombinant Human Chorionic Gonadotropin Study Group. Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment-recombinant HCG versus urinary HCG. Hum Reprod 2000, 15(7): 1446-1451
52. Driscoll, G.L., Tyler, J.P., Hangan, J.T., Fisher, P.R., Birdsall, M.A., Knight, D.C. A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation. Hum Reprod 2000, 15(6): 1305-1310
53. Chang, P., Kenley, S., Burns, T, Denton, G., Currie, K., DeVane, G., O'Dea, L. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril 2001, 76(1): 67-74. (Pubitemid 32600961)
54. Schoot, D.C., Harlin, J., Shoham, Z. et al. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum Reprod 1994, 9(7): 1237-1242 (Pubitemid 24223987)
55. Shoham, Z., Balen, A., Patel, A., Jacobs, H.S. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril 1991, 56(6): 1048-1053
56. Labrie, F., Auclair, C., Cusan, L. et al. Inhibitory effects of treatment with LHRH or its agonists on ovarian receptor levels and function. Adv Exp Med Biol 1979, 112: 687-693
57. Bouchard, P., Fauser, BC. Gonadotropin-releasing hormone antagonist: New tools vs. old habits. Fertil Steril 2000, 73(1): 18-20. (Pubitemid 30018015)
58. Diedrich, K., Diedrich, E., Santos, E. et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist cetrorelix during ovarian stimulation. Hum Reprod 1994, 9(5): 788-791 (Pubitemid 24168059)
59. The Ganirelix Dose-Finding Study Group. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonists ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). Hum Reprod 1998, 13(11): 3023-3031
60. Olivennes, F., Cunha-Filho, J.S., Fanchin, R., Bouchard, P., Frydman, R. The use of GnRH antagonists in ovarian stimulation. Hum Reprod Update 2002, 8(3): 279-290 (Pubitemid 34618945)
61. Al-lnany, H.G., Abou-Setta, A.M., Aboulghar, M. Gonadotrophin-releasing hormone antagonists for assisted conception: A Cochrane review. Reprod Biomed Online 2007, 14(5): 640-649 (Pubitemid 46772828)
62. Hammond, M.G., Halme, J.K., Talbert, L.M. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol 1983, 62(2): 196-202.
63. Zarate, A., Hernandez-Ayup, S., Ris-Montiel, A. Treatment of anovulation in the Stein-Leventhal syndrome. Analysis of 90 cases. Fertil Steril 1971, 22(3): 188-193
64. Raj, S.G., Thompson, I.E., Berger, M.J., Taymor, M.L. Clinical aspects of polycystic ovary syndrome. Obstet Gynecol 1977, 49(5): 552-556 (Pubitemid 8106775)
65. Claman, P., Wilkie, V., Collins, D. Timing intrauterine insemination either 33 or 39 hours after administration of human chorionic gonadotropin yields the same pregnancy rates as after superovulation therapy. Fertil Steril 2004, 82(1): 13-16 (Pubitemid 38968767)
66. Nugent, D., Vandekerckhove, P., Hughes, E., Arnot, M., Lilford, R. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database of Syst Rev 2000(3): CD000410.
67. Bayram, N., van Wely, M., van der Veen, F. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database of Syst Rev 2001(2): CD002121.
68. Loumaye, E. Clinical assessment of human gonadotrophins produced by recombinant DNA technology Hum Reprod 1996, 11(S1): 95-107.
69. Bennink, H.J.C., Fauser, B.C., Out, H.J. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: A prospective, multicenter, assessor-blind, randomized, clinical trial. Fertil Steril 1998, 69(1): 19-25.
70. Yarali, H., Bukulmez, O., Gurgan, T. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic, chronic anovulation: A prospective randomized study. Fertil Steril 1999, 72(2): 276-81. (Pubitemid 29364623)
71. Porter, R.N., Smith, W., Craft, I.L., Abdulwahid, N.A., Jacobs, H.S. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 1984, 2: 1284-1285 (Pubitemid 15217748)
72. Fleming, R., Coutts, J.R. Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 1986, 45(2): 226-230 (Pubitemid 16127138)
73. Schmutzler, R.K., Reichert, C., Diedrich, K. et al. Combined GnRH-agonist/gonadotrophin stimulation for in-vitro fertilization. Hum Reprod 1988, 3(2): 29-33. (Pubitemid 18239538)
74. Wildt, L., Diedrich, H., van der Ven, G., Al-Hasani, S., Hubner, H., Klasen, R. Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins. Hum Reprod 1986, 1(1): 15-19 (Pubitemid 16112424)
75. Muasher, S.J. Use of gonadotrophin-releasing hormone agonists in controlled ovarian hyperstimulation for in vitro fertilisation. Clin Ther 1992, 14(Suppl A): 74-86.
76. Arslan, M., Bocca, S., Mirkin, S., Barroso, G., Stadtmauer, L., Oehninger, S. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Can. Fertil Steril 2005, 84(3): 555-569 (Pubitemid 41317707)
77. Blumenfeld, Z. Recombinant FSH vs. urinary FSH-retrospective study of matched pairs for type of treatment (IVF or ICSI). Fertil Steril 2001, 76(6): 1289-1290 (Pubitemid 33116410)
78. Gleicher, N., Vietzke, M., Vidali, A. Bye-bye urinary gonadotrophins? Recombinant FSH: A real progress in ovulation induction and IVF? Hum Reprod 2003, 18(3): 476-482
79. Daya, S., Gunby, J., Hughes, E.G., Collins, J.A., Sagle, M.A. Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: A meta-analysis. Fertil Steril 1995, 64(2): 347-354 (Pubitemid 26027399)
80. Out, H.J., Mannaerts, B.M , Driessen, S.G., Bennink, H.J. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod 1995, 10(10): 2534-2540
81. Out, H.J., Driessen, S.G., Mannaerts, B.M., Bennink, H.J. Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins. Fertil Steril 1997, 68(1): 138-142
82. Recombinant Human FSH Study Group. Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil Steril 1995, 63: 77-86.
83. Hedon, B., Out, H.J., Hughes, J.N., et al. Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: A prospective, randomized, assessor-blind, multicentre trial. Hum Reprod 1995, 10(12): 3102-6. (Pubitemid 26026503)
84. Agrawal, R., Holmes, J., Jacobs, H.S. Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: A meta-analysis. Fertil Steril 2000, 73(2): 338-343 (Pubitemid 30060370)
85. The European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone. Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: A randomized, comparative trial. Fertil Steril 2002, 78(3): 520-528
86. Kilani, Z., Dakkak, A., Ghunaim, S. et al. A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: Ovarian response and clinical outcomes. Hum Reprod 2003, 18(6): 1194-1199 (Pubitemid 36740563)
87. Dickey, R.P., Thornton, M., Nichols, J., Marshall, D.C., Fein, S.H., Nardi, R.V. Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle) and recombinant follitropin-beta for in vitro fertilization: A prospective, randomized study. Fertil Steril 2002, 77(6): 1202-1208 (Pubitemid 34626330)
88. Daya, S. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction. Fertil Steril 2002, 77(4): 711-714 (Pubitemid 34275349)
89. Hugues, J., Bry-Gauillard, H., Standig, B., Uazn, M., Cedrin-Durnerin, I. Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization-embryo transfer. J Assist Reprod & Gen 2001, 18(4): 191-196 (Pubitemid 32574597)
90. Al-lnany, H.G., Aboulghar, M., Mansour, R., Serour, G. Meta-analysis of recombinant versus urinary-derived FSH: An update. Hum Reprod 2003, 18(2): 305-313 (Pubitemid 36236263)
91. Papanikolaou, E.G., Camus, M., Kolibianakis, E.M., Van Landuyt, L., Van Steirteghem, A., Devroey, P. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. NEJM 2006, 354: 1139-1146
92. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2006 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports, Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2008. http://www.cdc.gov/art/ART2006/508PDF/ 2006ART.pdf. Accessed April 18, 2009.
93. Jain, T., Gupta, R.S. Trends in the use of intracytoplasmic sperm injection in the United States. NEJM 2007, 357(3): 251-257 (Pubitemid 47080389)
94. The Practice Committee of the Society for Assisted Reproductive Technology and the Practice Committee for the American Society for Reproductive Medicine. The role of assisted hatching in in vitro fertilization: A review of the literature. A committee opinion. Fertil Steril 2006, 86(5S): S124-6.
95. Tan, S.L., Child, T.J. In vitro maturation of oocytes from unstimulated polycystic ovaries. Reprod Biomed Online 2002, 4(S1): 18-23.
96. Mikkelsen, A.L., Smith, S.D., Lindenberg, S. In-vitro maturation of human oocytes from regularly menstruating women may be successful without follicle stimulating hormone priming. Hum Reprod 1999, 14(7): 1847-1851 (Pubitemid 29358712)
97. Al-Sunaidi, M., Tulandi, T., Holzer, H., Sylvestre, C., Chian, R., Tan, S. Repeated pregnancies and live births after in vitro maturation treatment. Fertil Steril 2007, 87(5): 1212.e9-12 (Pubitemid 46659933)
98. Chian, R. In vitro maturation of immature oocytes for infertile women with PCOS. Reprod Biomed Online 2004, 8(5): 547-52.
99. Child, T.J., Phillips, S.J., Abdul-Jalil, A.K., Gulekli, B., Tan S.L. A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries. Obstet & Gynecol 2002, 100(4): 665-670 (Pubitemid 35300020)